205 related articles for article (PubMed ID: 11792868)
1. Ku86 is essential in human somatic cells.
Li G; Nelsen C; Hendrickson EA
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):832-7. PubMed ID: 11792868
[TBL] [Abstract][Full Text] [Related]
2. Heterozygous inactivation of human Ku70/Ku86 heterodimer does not affect cell growth, double-strand break repair, or genome integrity.
Uegaki K; Adachi N; So S; Iiizumi S; Koyama H
DNA Repair (Amst); 2006 Mar; 5(3):303-11. PubMed ID: 16325483
[TBL] [Abstract][Full Text] [Related]
3. The lethality of Ku86 (XRCC5) loss-of-function mutations in human cells is independent of p53 (TP53).
Ghosh G; Li G; Myung K; Hendrickson EA
Radiat Res; 2007 Jan; 167(1):66-79. PubMed ID: 17214517
[TBL] [Abstract][Full Text] [Related]
4. An antisense oligonucleotide targeted to human Ku86 messenger RNA sensitizes M059K malignant glioma cells to ionizing radiation, bleomycin, and etoposide but not DNA cross-linking agents.
Belenkov AI; Paiement JP; Panasci LC; Monia BP; Chow TY
Cancer Res; 2002 Oct; 62(20):5888-96. PubMed ID: 12384553
[TBL] [Abstract][Full Text] [Related]
5. KARP-1: a novel leucine zipper protein expressed from the Ku86 autoantigen locus is implicated in the control of DNA-dependent protein kinase activity.
Myung K; He DM; Lee SE; Hendrickson EA
EMBO J; 1997 Jun; 16(11):3172-84. PubMed ID: 9214634
[TBL] [Abstract][Full Text] [Related]
6. Translocation of Ku86/Ku70 to the multiple myeloma cell membrane: functional implications.
Tai YT; Podar K; Kraeft SK; Wang F; Young G; Lin B; Gupta D; Chen LB; Anderson KC
Exp Hematol; 2002 Mar; 30(3):212-20. PubMed ID: 11882358
[TBL] [Abstract][Full Text] [Related]
7. Ku86 variant expression and function in multiple myeloma cells is associated with increased sensitivity to DNA damage.
Tai YT; Teoh G; Lin B; Davies FE; Chauhan D; Treon SP; Raje N; Hideshima T; Shima Y; Podar K; Anderson KC
J Immunol; 2000 Dec; 165(11):6347-55. PubMed ID: 11086072
[TBL] [Abstract][Full Text] [Related]
8. Regulation of telomere length and suppression of genomic instability in human somatic cells by Ku86.
Myung K; Ghosh G; Fattah FJ; Li G; Kim H; Dutia A; Pak E; Smith S; Hendrickson EA
Mol Cell Biol; 2004 Jun; 24(11):5050-9. PubMed ID: 15143195
[TBL] [Abstract][Full Text] [Related]
9. Transfer of Ku86 RNA antisense decreases the radioresistance of human fibroblasts.
Marangoni E; Le Romancer M; Foray N; Muller C; Douc-Rasy S; Vaganay S; Abdulkarim B; Barrois M; Calsou P; Bernier J; Salles B; Bourhis J
Cancer Gene Ther; 2000 Feb; 7(2):339-46. PubMed ID: 10770645
[TBL] [Abstract][Full Text] [Related]
10. Ku86 represses lethal telomere deletion events in human somatic cells.
Wang Y; Ghosh G; Hendrickson EA
Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12430-5. PubMed ID: 19581589
[TBL] [Abstract][Full Text] [Related]
11. Human normal peripheral blood B-lymphocytes are deficient in DNA-dependent protein kinase activity due to the expression of a variant form of the Ku86 protein.
Muller C; Dusseau C; Calsou P; Salles B
Oncogene; 1998 Mar; 16(12):1553-60. PubMed ID: 9569022
[TBL] [Abstract][Full Text] [Related]
12. Role of human Ku86 in telomere length maintenance and telomere capping.
Jaco I; Muñoz P; Blasco MA
Cancer Res; 2004 Oct; 64(20):7271-8. PubMed ID: 15492246
[TBL] [Abstract][Full Text] [Related]
13. Hypersensitivity of Ku-deficient cells toward the DNA topoisomerase II inhibitor ICRF-193 suggests a novel role for Ku antigen during the G2 and M phases of the cell cycle.
Muñoz P; Zdzienicka MZ; Blanchard JM; Piette J
Mol Cell Biol; 1998 Oct; 18(10):5797-808. PubMed ID: 9742097
[TBL] [Abstract][Full Text] [Related]
14. Deletion of Ku86 causes early onset of senescence in mice.
Vogel H; Lim DS; Karsenty G; Finegold M; Hasty P
Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10770-5. PubMed ID: 10485901
[TBL] [Abstract][Full Text] [Related]
15. Ku86 defines the genetic defect and restores X-ray resistance and V(D)J recombination to complementation group 5 hamster cell mutants.
Errami A; Smider V; Rathmell WK; He DM; Hendrickson EA; Zdzienicka MZ; Chu G
Mol Cell Biol; 1996 Apr; 16(4):1519-26. PubMed ID: 8657125
[TBL] [Abstract][Full Text] [Related]
16. Mutations to Ku reveal differences in human somatic cell lines.
Fattah KR; Ruis BL; Hendrickson EA
DNA Repair (Amst); 2008 May; 7(5):762-74. PubMed ID: 18387344
[TBL] [Abstract][Full Text] [Related]
17. Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates.
Zhu C; Bogue MA; Lim DS; Hasty P; Roth DB
Cell; 1996 Aug; 86(3):379-89. PubMed ID: 8756720
[TBL] [Abstract][Full Text] [Related]
18. Human colon carcinoma cell-line HCT116 transfected by antisense cDNA as a tool to study the Ku86 involvement in cell proliferation.
Sadji Z; Le Romancer M; Lewin MJ; Reyl-Desmars F
Cell Signal; 2000 Dec; 12(11-12):745-50. PubMed ID: 11152960
[TBL] [Abstract][Full Text] [Related]
19. Senescent human fibroblasts have elevated Ku86 proteolytic cleavage activity.
Jeng YW; Chao HC; Chiu CF; Chou WG
Mutat Res; 1999 Dec; 435(3):225-32. PubMed ID: 10606813
[TBL] [Abstract][Full Text] [Related]
20. Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres.
Espejel S; Franco S; Rodríguez-Perales S; Bouffler SD; Cigudosa JC; Blasco MA
EMBO J; 2002 May; 21(9):2207-19. PubMed ID: 11980718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
